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Neighborhood socioeconomic environment may be a determinant of injection drug use cessation. The authors
used data from a prospective cohort study of Baltimore City, Maryland, injection drug users assessed between 1990
and 2006. The study examined the relation between living in a poorer neighborhood and the probability of injection
cessation among active injectors, independent of individual characteristics and while respecting the temporality of
potential confounders, exposure, and outcome. Participants’ residences were geocoded, and the crude, adjusted,
and inverse probability of exposure weighted associations between neighborhood poverty and injection drug use
cessation were estimated. Weighted models showed a strong association between neighborhood poverty and in-
jection drug use cessation; living in a neighborhood with fewer than 10%, compared with more than 30%, of residents
in poverty was associated with a 44% increased odds of not injecting in the prior 6 months (odds ratio ¼ 1.44, 95%
confidence interval: 1.14, 1.82). Results show that neighborhood environment may be an important determinant of
drug injection behavior independent of individual-level characteristics.
drug users; epidemiologic methods; heroin; poverty; residence characteristics; social environment; substance-
related disorders
Abbreviations: ALIVE, AIDS Link to Intravenous Experience; CI, confidence interval; HIV, human immunodeficiency virus; IDU,
injection drug user; IPW, inverse probability weight; OR, odds ratio.
In 2003, an estimated 13.2 million adults worldwide in-
jected drugs, with approximately 22% of injection drug
users (IDUs) residing in developed countries (1). Injection
drug use has been one of the 2 most common routes for the
spread of human immunodeficiency virus (HIV) infection
worldwide since the beginning of the pandemic, either di-
rectly through the sharing of contaminated syringes and in-
jection equipment or indirectly through engaging in other
risk behaviors associated with injection drug use, including
sexual risk behaviors (2). In the United States, urban areas
have been disproportionately affected by the dual epidemics
of injection drug use and HIV (3). In Baltimore City,
Maryland, for example, the per capita prevalence of injec-
tion drug use is 162 per 10,000 population, second among
the largest metropolitan statistical areas in the United States
(4), and the 14% prevalence of HIV among IDUs in 1998
ranked the city 11th among the largest metropolitan statis-
tical areas in the United States (5).
Optimal prevention of the morbidity and mortality asso-
ciated with injection drug use can best be achieved through
injection cessation. The most commonly studied predictors
of injection cessation have been individual-level character-
istics relating to socioeconomic status, drug use behaviors,
social and drug networks, and treatment access (6–11).
However, a potential limitation of this approach is that the
individualistic interventions it informs may not adequately
address the underlying forces driving the prevalence and
distribution of risk factors for injection drug use in the pop-
ulation. For example, a recent study of drug users dis-
charged from community-based outpatient and residential
treatment facilities in Los Angeles County, California,
found that the location of treatment facilities may actually
391 Am J Epidemiol 2010;171:391–398
increase clients’ exposures to potential neighborhood-level
stimuli for relapse, including neighborhood disadvantage,
violence, and drug activity (12).
Prominent sociologists, including William Julius Wilson,
have proposed that the maladies plaguing urban areas of the
United States, including the concentration of poverty and
drug use, particularly among blacks, should be understood
within a broader historical context of deindustrialization and
declining job opportunities (13–16). Baltimore City, for ex-
ample, has experienced a precipitous loss of its manufactur-
ing base; accompanying these economic changes have been
dramatic social and demographic shifts that have affected
the neighborhood environment (17). The neighborhood en-
vironment, particularly levels of neighborhood poverty, may
influence the likelihood of drug injection cessation.
A growing body of research shows that the primary de-
terminant of cessation is the proportion of one’s interactions
with IDU subculture (10, 18, 19). Borrowing from symbolic
interactionist thought (20), decreasing the proportion of in-
teractions with drug use subculture and increasing the pro-
portion of positive reference groups may produce the role
strain necessary for inducing a shift out of IDU identity and
promoting injection cessation. More affluent and socially
cohesive neighborhoods may engender the positive social
interactions and attendant financial and emotional resources
that may decrease the proportion of one’s interactions with
IDU subculture and increase the likelihood of cessation. As
such, the neighborhood environment may be an important
determinant of injection cessation. A better understanding
of how the urban environment influences patterns of injec-
tion drug use may facilitate the development of more effec-
tive interventions to mitigate the morbidity and mortality
associated with injection drug use.
One of the most important challenges to causal inference
in observational studies of intra-urban, small-area (typically
called ‘‘neighborhood’’) characteristics and health indica-
tors is the nonrandom process through which individuals
are selected into different neighborhoods based on attributes
that may be associated with their health (21, 22). Most
neighborhood effects studies attempt to address selection
into neighborhoods and isolate the effect of a particular
neighborhood exposure by using standard methods such
as regression or propensity score matching to adjust for
individual-level covariates that may be associated with sub-
sequent neighborhood exposure and may be predictive of
the outcome. However, this approach can be problematic
because the potential confounders frequently adjusted for
in neighborhood effects studies may be time-varying con-
founders affected by prior exposure. Controlling for such
variables by using standard methods may yield biased esti-
mates of the total causal effect of a neighborhood exposure
by overcontrolling for covariates on the pathway between
a neighborhood exposure and outcome or by inducing
collider-stratification bias (23). One method for handling
such variables is to fit models by using inverse probability
weights (IPWs). Such models allow for the control of time-
fixed and time-varying variables without conditioning on
these variables (24–27).
Few studies have handled selection into neighborhoods in
a meaningful way, and, to our knowledge, only one multi-
level study previously used IPWs to address the issue of
selection into neighborhoods (28). Here, we build on this
work by using multilevel models fitted with stabilized IPWs
to assess the relation between living in a poorer neighbor-
hood and the probability of injection cessation in a longitu-




The rationale, design, and methods of the AIDS Link to
Intravenous Experience (ALIVE) cohort study have been
described in detail previously (29). Briefly, beginning in
1988–1989, the ALIVE study recruited 2,946 IDUs through
community outreach in Baltimore City. For this initial re-
cruitment period, individuals were eligible to participate in
the study if they reported injection drug use within the past
11 years; were at least 18 years of age; and, for HIV-positive
participants, were free of acquired immunodeficiency syn-
drome at study entry. Since the initial recruitment period,
there has been additional recruitment using similar eligibil-
ity criteria in 1994–1995, 1998, 2000, and 2005–2007.
ALIVE participants are followed up semiannually, with an-
nual retention rates of approximately 90%–95% over the
last decade. The address of their residence, provided by re-
spondents at each ALIVE study visit, is geocoded to the US
Census tract level.
For these analyses, additional inclusion and exclusion
criteria were applied. After excluding 1,307 visits for which
there was invalid or no identifiable address information, we
geocoded 41,378 of 42,083 (98.3%) visits between January
1, 1988, and December 31, 2005. We excluded 2,245 visits
geocoded to census tracts outside of Baltimore City. Addi-
tionally, 4,375 visits that mapped to 15 of the 200 census
tracts in Baltimore City with 1) more than one-quarter of
their population living in group quarters (e.g., a correctional
institution, nursing home, or college dormitory) or 2) un-
stable data (e.g., census tracts in which most of the area is
zoned for a park or cemetery) were excluded. Of the remain-
ing 34,758 visits, we restricted the sample to ‘‘active’’ in-
jectors at baseline by excluding 2,325 visits from
participants who reported at baseline that they had not in-
jected within the past 6 months. A total of 6,714 visits were
excluded to allow for covariates to be lagged up to 2 visits
and to restrict the analysis to visits from the 1988–1989,
1994–1995, 1998, and 2000 ALIVE recruitment phases that
occurred between the beginning of 1990 and the end of
2005. Regarding the remaining 25,719 visits, the final anal-
ysis was based on 19,054 visits for which there was com-
plete information on covariates of interest.
Neighborhood-level measures
Census tracts were used as proxies for Baltimore City
neighborhoods. We used the 1990 decennial US Census to
obtain the percentage of residents living in poverty per
census tract (30) and merged these data with each partic-
ipant visit. Our analyses included 174 census tracts, and
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the median number of visits per tract was 88 (25th percen-
tile ¼ 35, 75th percentile ¼ 201). The percentage of the
population living in poverty has been used previously to
describe social inequities in health (31, 32). We split our
primary exposure, percentage of neighborhood poverty,
into 4 categories with cutpoints at 10%, 20%, and 30%.
These cutpoints were selected because approximately one-
quarter of Baltimore City census tracts fall into each of the
4 categories. Additionally, selection of these categories
facilitates comparison with other research on neighbor-
hood poverty that uses 20%, the federal definition of
a ‘‘poverty area,’’ as a cutpoint.
Individual-level measures
Information on a number of individual-level characteris-
tics is collected from ALIVE participants at each semian-
nual visit. Data are gathered on sociodemographic
characteristics (gender, age, race/ethnicity, educational at-
tainment, employment in the formal economy, formal in-
come), drug use characteristics (age at first injection,
needle sharing, crack use, shooting gallery attendance), sex-
ual behaviors, medical history (HIV status, presence of any
sexually transmitted diseases), health care utilization (meth-
adone treatment usage), and life events (homelessness, jail/
incarceration), among other characteristics. The demo-
graphics and risk behavior portions of the questionnaire
were interview administered initially and were converted
to audio computer-assisted self-interview in 1998 because
the latter was found to yield higher reports of sensitive
behaviors, both in the ALIVE cohort and in other studies
(33, 34).
At each visit, participants were asked whether they had
injected drugs in the past 6 months. Consistent with other
research on cessation (6, 8, 10, 35), we defined our outcome
measure, cessation, as not injecting drugs within the prior 6
months.
We included measures on a set of time-fixed and time-
varying potentially confounding covariates. The selection of
time-fixed and time-varying covariates was determined a pri-
ori based on previous analyses from this and other cohorts
on drug injection cessation. For these analyses, gender, race/
ethnicity (dichotomized as black or other), educational at-
tainment (dichotomized as less than or greater than or equal
to high school), and age at first injection (dichotomized as
less than or greater than or equal to 20 years) were treated as
time-fixed covariates. Current age (dichotomized at age 35
years), current employment status (dichotomized as not em-
ployed or employed), formal income in the past 6 months
(dichotomized as less than or greater than or equal to
$2,500), number of days incarcerated in the past 6 months
(dichotomized as less than or greater than or equal to 1
week), homelessness in the past 6 months (dichotomized
as no or yes), current HIV status (dichotomized as negative
or positive), current infection with any sexually transmitted
disease other than chlamydia (dichotomized as no or yes),
crack use in the past 6 months (dichotomized as no or yes),
needle sharing in the past 6 months (dichotomized as no or
yes), shooting gallery attendance in the past 6 months (di-
chotomized as no or yes), and receipt of methadone treat-
ment in the past 6 months (dichotomized as no or yes) were
treated as time-varying covariates.
Statistical analyses
We ran 4 multilevel logistic regression models with
nested random intercepts to account for within-person and
within-neighborhood clustering, as described elsewhere
(36). Consistent with the observation of frequent transitory
patterns of drug use in the ALIVE cohort (37), which show
that IDUs often shift between periods of injection and ab-
stinence within 6 months, cessation was defined as a repeat-
able outcome and participants remained at risk even after
their first report of cessation.
In the first model, we examined the crude or unadjusted
relation between neighborhood poverty and cessation by
regressing the odds of not injecting in the past 6 months
measured at visit k on categories of neighborhood poverty
measured at the prior visit, k  1. Second, we assessed the
relation between neighborhood poverty and cessation after
adjusting for time-fixed baseline covariates. Third, we as-
sessed the fully adjusted relation by regressing the odds of
not injecting in the past 6 months at visit k on categories of
neighborhood poverty at k  1, while controlling for time-
fixed covariates and time-varying covariates measured 2
visits prior to the outcome at k  2. Fourth, we removed
the time-varying covariates from the logistic regression
model but accounted for measured time-varying confound-
ing and right-censoring due to losses to follow-up by
weighting each participant visit using stabilized inverse
probability of exposure and censoring weights (27, 38), as
formally specified in the Appendix.
We assessed the distribution of the weights and trun-
cated them at the 1st and 99th percentiles (mean ¼ 1.00,
median ¼ 0.65, 1st percentile ¼ 0.08, 99th percentile ¼
6.48) (38). The association between neighborhood poverty
and the odds of not injecting in the past 6 months was
assessed by regressing the odds of not injecting at time k
on categories of neighborhood poverty measured at k  1
and the set of time-fixed covariates by using a stabilized
inverse probability weighted multilevel logistic regression
model. All analyses were conducted with the SAS statisti-
cal package, version 9.1.3 (SAS Institute, Inc., Cary, North
Carolina).
RESULTS
The sample for this analysis consisted of 1,875 IDUs who
contributed 19,054 study visits (median, 7; interquartile
range, 3–12). The baseline (first visit) characteristics and
balance of covariates across categories of neighborhood
poverty are shown in Table 1. Among visits in each category
of neighborhood poverty, participants reported not injecting
drugs in the past 6 months at 4,887 of 11,807 (41%) visits in
neighborhoods with greater than 30% of residents in pov-
erty, 1,637 of 3,290 (50%) visits in neighborhoods with
20%–30% of residents in poverty, 1,312 of 2,417 (54%) of
visits in neighborhoods with 10%–20% of residents in pov-
erty, and 918 of 1,540 (60%) of visits in neighborhoods with
less than 10% of residents in poverty (Table 2).
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Both unadjusted models and models adjusted for time-
fixed baseline covariates showed a significant dose-response
relation between neighborhood poverty and the probability
of cessation (Table 2); compared with living in a neighbor-
hood in the highest category of poverty, living in a neighbor-
hood in the second, third, and fourth (lowest poverty)
categories of poverty was associated with 11% (odds ratio
(OR)¼ 1.11, 95% confidence interval (CI): 0.99, 1.26), 19%
(OR¼ 1.19, 95% CI: 1.06, 1.33), and 44% (OR¼ 1.44, 95%
CI: 1.22, 1.69) increased odds of not injecting in the prior 6
months, respectively, after adjusting for baseline covariates.
However, these associations were substantially attenuated
after adjusting for time-varying covariates. Fully adjusted
models (Table 2) show that, relative to living in a neighbor-
hood in the highest category of poverty, living in a neighbor-
hood in the lowest category of poverty was associated with
an attenuated odds of cessation (OR ¼ 1.16, 95% CI: 0.97,
1.38).
In models fit by stabilized IPWs, we found that neighbor-
hood poverty was a strong predictor of injection drug use
Table 1. Baseline (First Visit) Characteristics and Balance of Covariates Across Levels of Neighborhood Povertya Among 1,875 Baltimore City,
Maryland, Injection Drug Users Assessed Between 1990 and 2006




£30% (n 5 297)
Poverty >10% but
£20% (n 5 214)
Poverty £10%
(n 5 108)
No. % No. % No. % No. % No. %
Age 35 years 666 36 469 37 100 34 63 29 34 31
Female gender 477 25 329 26 63 21 62 29 23 21
Black race 1,780 95 1,221 97 279 94 190 89 90 83
<High school education 1,049 56 737 59 151 51 103 48 55 51
Employedb 440 23 278 22 72 24 58 27 32 30
Formal income <$2,500b 1,484 79 1,022 81 233 78 156 73 73 68
Incarcerated 1 weekb 288 15 189 15 44 15 37 17 18 17
Homelessb 293 16 201 16 48 16 30 14 14 13
HIV positive 676 36 447 36 109 37 86 40 34 31
Any STD 102 5 67 5 18 6 13 6 4 4
Age at first injection <20 years 908 48 590 47 152 51 116 54 57 53
Needle sharingb 560 30 398 32 94 32 41 19 27 25
Crack useb 381 20 255 20 57 19 51 24 18 17
Shooting gallery attendanceb 158 8 99 8 33 11 15 7 11 10
Methadone treatmentb 186 10 114 9 37 12 24 11 11 10
Abbreviations: HIV, human immunodeficiency virus; STD, sexually transmitted disease.
a Neighborhood poverty based on percentage of residents living in poverty per US Census tract of residence.
b In the past 6 months.
Table 2. Crude, Baseline Adjusted, Fully Adjusted, and Inverse Probability Weighted Odds of not Injecting in the Prior 6 Months, by Level of
Neighborhood Poverty Reported at Prior Visit, for 1,875 Baltimore City, Maryland, Injection Drug Users With 19,054 Semiannual Study Visits











OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Poverty >30% (reference) 4,887 11,807 1 1 1 1
Poverty >20% but 30% 1,637 3,290 1.11 0.99, 1.24 1.11 0.99, 1.26 0.98 0.86, 1.11 1.20 1.03, 1.41
Poverty >10% but 20% 1,312 2,417 1.17 1.03, 1.33 1.19 1.06, 1.33 1.01 0.87, 1.16 1.35 1.12, 1.63
Poverty 10% 918 1,540 1.42 1.21, 1.67 1.44 1.22, 1.69 1.16 0.97, 1.38 1.44 1.14, 1.82
Abbreviations: CI, confidence interval; IPW, inverse probability weight; OR, odds ratio.
a Neighborhood poverty based on percentage of residents living in poverty per US Census tract of residence.
b Within-person and within-neighborhood clustering accounted for by using nested random intercepts.
c Adjusted for baseline covariates (gender, race, educational attainment, age at first injection).
d Adjusted for covariates measured one visit prior to neighborhood poverty (age, employment, formal income, jail, homelessness, human
immunodeficiency virus status, any sexually transmitted disease, needle sharing, crack use, shooting gallery attendance, methadone treatment).
e Weighted for baseline covariates and covariates measured 6 months prior to neighborhood poverty: level of neighborhood poverty, outcome
status, age, employment, formal income, jail, homelessness, human immunodeficiency virus status, any sexually transmitted disease, needle
sharing, shooting gallery attendance, methadone treatment.
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regardless of prior neighborhood (Table 2). Compared with
living in a neighborhood in the highest category of poverty,
living in a neighborhood in the second, third, and fourth
(lowest poverty) categories of poverty was associated with
20% (OR ¼ 1.20, 95% CI: 1.03, 1.41), 35% (OR ¼ 1.35,
95% CI: 1.12, 1.63), and 44% (OR ¼ 1.44, 95% CI: 1.14,
1.82) increased odds of not injecting in the prior 6 months,
respectively.
DISCUSSION
We used data from a longitudinal cohort of 1,875 IDUs in
Baltimore City to investigate the association between living
in a poorer neighborhood and the probability of injection
cessation. Inverse probability weighted models showed that
IDUs living in more impoverished neighborhoods were less
likely to stop injecting drugs, independent of individual-
level covariates.
We examined the sensitivity of results to different mod-
eling strategies for handling selection into neighborhoods.
After finding an inverse dose-response association between
levels of poverty and the probability of injection cessation in
both crude unadjusted models and models adjusted for time-
fixed baseline covariates, we used multivariable regression
to adjust for an array of measured individual-level covari-
ates hypothesized to influence our exposure and outcome;
this approach is commonly utilized by neighborhood effects
studies (refer, for example, to Nandi et al. (39), Williams
and Latkin (40), Wu et al. (41), and Maas et al. (42)). We
then compared these results with those from a stabilized
inverse probability weighted regression model with random
effects.
Overall, there was a significant inverse association be-
tween neighborhood poverty and the probability of cessa-
tion in models that used IPW to handle confounding but not
when the traditional regression approach was used. These
divergent results suggest that use of traditional regression to
handle confounding in neighborhood effects studies may
induce bias because the individual-level characteristics fre-
quently adjusted for may be time-varying covariates af-
fected by prior exposure. For example, as illustrated in
Figure 1, time-varying covariates such as employment in
the formal economy may predict whether a drug user lives
in a relatively wealthier neighborhood. In turn, living in
a wealthier neighborhood may influence future employment
prospects and the probability of drug injection cessation.
Similarly, drug use covariates related to a drug user’s pro-
clivity for injecting with others may predict whether a drug
user lives in a poorer neighborhood with more shooting
galleries versus a relatively richer neighborhood with fewer
opportunities to share injection equipment, which may then
influence injection behaviors during a subsequent time
period.
Analyses of our data showed that sociodemographic char-
acteristics, particularly employment status, were time-
varying covariates affected by prior levels of exposure. By
adjusting for individual-level factors related to socioeco-
nomic status, studies on drug use may overcontrol for co-
variates on the pathway between a neighborhood exposure
and outcome or induce selection bias due to collider strati-
fication (24–27). Further neighborhood effects research
should investigate the use of IPWs for handling confounding
due to determinants of neighborhood selection.
Although work on the influence of the neighborhood en-
vironment on injection drug use cessation is sparse, our
main finding of an inverse association between neighbor-
hood poverty and the probability of cessation is consistent
with prior observational work on illicit drug use (40, 43–49).
For example, a study of 1,305 adults recruited from high-
drug-risk areas in Baltimore City found that neighborhood
poverty was significantly associated with current heroin and
cocaine use even after accounting for network attributes
(40); another analysis conducted among 835 adults from
the same study population showed that IDUs in more disor-
dered Baltimore neighborhoods had higher levels of depres-
sion and that depression was associated with greater
injection frequency (47).
The level of socioeconomic deprivation in a neighborhood
may influence the probability of cessation through a number
of distinct pathways. For example, less impoverished neigh-
borhoods may engender a social context more conducive to
cessation through the enforcement of informal social control
mechanisms and subsequent inhibition of dense drug use
networks, as well as through the promotion of resources
facilitating integration into mainstream society and the for-
mal economy. The potential importance of the social envi-
ronment in less socioeconomically deprived neighborhoods
is supported by work showing associations between levels
of disorder and the extent of drug use networks and between
drug use networks and individual cessation (10, 50).
An alternative mechanism relates to the material environ-
ment of neighborhoods. For example, less impoverished
neighborhoods may inhibit opportunities for purchasing
drugs while promoting access to treatment resources.
Clearly, a combination of these potential mechanisms, as
well as others not discussed here, may explain the associa-
tion we observed. Future work should focus on elucidating
Figure 1. Causal diagram of the effect of neighborhood poverty on
cessation of injection drug use (IDU). ‘‘Covariates’’ denote time-
varying variables (i.e., age, employment, formal income, jail, home-
lessness, human immunodeficiency virus status, any sexually
transmitted disease, sharing needles, crack use, shooting gallery
attendance, methadone treatment) measured one visit prior to
neighborhood poverty; ‘‘U ’’ denotes unmeasured characteristics.
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the pathways between socioeconomic deprivation and ces-
sation of injection drug use.
There were a number of limitations to this study. First, the
use of IPWs does not address unmeasured confounding. We
attempted to minimize unmeasured confounding by includ-
ing measures of as many recognized potential confounders
as possible. Second, our weights were not multiplied across
time and therefore do not account for cumulative effects of
neighborhood poverty on cessation. However, longitudinal
patterns of injection in the ALIVE study show that patterns
of relapse are substantially more frequent than patterns of
consistent abstinence of injection drug use (37), suggesting
that the immediate 6-month interval preceding each study
visit may be more important than long-term cumulative ef-
fects with respect to injection patterns. Third, we used only
those variables measured in the prior 6 months as predictors
in our weight models. To assess the sensitivity of our results
to this decision, we conducted an analysis that incorporated
the prior 2 visits in our weight models and found that our
effect estimates did not change appreciably. Fourth, we ex-
cluded a number of visits, including those when a participant
did not provide identifiable address information and those
for which information on covariates of interest was missing.
This exclusion may have introduced selection bias. How-
ever, the ALIVE study has standardized procedures for data
collection and quality control and has minimized occurrence
of missing data, particularly given its transient drug-using
study population. Additionally, the distributions of key de-
mographic factors were not significantly different in the
study sample before and after missing visits were excluded.
Fifth, we excluded residences outside of Baltimore City
because they represented a limited number of contributions
as well as visits during which the participant reported no
address/homelessness. However, this occurrence was rela-
tively uncommon, and we geocoded visits to shelter ad-
dresses if provided. Sixth, respondents were geocoded to
their census tract of residence. It is plausible that respon-
dents are influenced by multiple contexts outside of their
own neighborhoods, and further work should attempt to
quantify the impact of multiple environments on drug in-
jection behaviors. Seventh, we relied on census tracts as
proxies for neighborhoods. Although census tracts are
a more practical unit of analysis because secondary data
are more commonly aggregated to these units, they may
be less sociologically valid to the extent that they represent
the underlying processes theorized to be significant to the
health of their residents. In this case, the availability of
census tract data outweighed the potential benefits of using
other boundaries, such as neighborhood statistical areas,
which may have been more sociologically valid. Finally,
we used 1990 US Census data to define our measure of
neighborhood poverty. Although levels of poverty changed
among Baltimore census tracts between 1990 and 2000,
a sensitivity analysis using linearly interpolated poverty
values produced qualitatively similar findings.
Our findings suggest that the neighborhood environment
may be an important determinant of drug injection behav-
iors independent of individual-level characteristics. In con-
trast to adjusted models, models fit with inverse probability
of exposure weights showed a robust association between
neighborhood poverty and the probability of injection ces-
sation. Future neighborhood effects research should con-
sider the use of IPW as a method to address confounding
by determinants of neighborhood selection, specifically for
handling time-varying confounders affected by prior expo-
sure. Some of the most important factors influencing persis-
tent drug use among IDUs may be the environments in
which risk is produced rather than individual-level factors
that are frequently the emphasis of drug use research.
Our work has important implications for treatment deliv-
ery. Pairing drug treatment with job training or other pro-
grams that facilitate mobility into more economically stable
neighborhood environments may increase the probability of
injection drug cessation. Further work elucidating the path-
ways linking the neighborhood environment to drug use
behaviors is warranted.
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APPENDIX
We fitted a hierarchical logistic regression model for the
repeated measurement of drug injection cessation of the
form









 ¼ b0 þ b1Xijk1 þ b2Vij0 þ cij þ ci;
where 1) Yijk ¼ 1 when participant j living in neighborhood i
reported not injecting drugs within the prior 6 months at
semiannual visit k; 2) Xijk represents the category of poverty
in the neighborhood that participant j lived in at visit k, such
that Xijk ¼ 1 indicates a neighborhood with greater than
30% of residents in poverty, Xijk ¼ 2 indicates a neighbor-
hood with 20%–30% poverty, Xijk ¼ 3 indicates a neighbor-
hood with 10%–20% poverty, and Xijk ¼ 4 indicates
a neighborhood with 0%–10% poverty; 3) Vij is a vector
of measured baseline covariates, including gender, race, ed-
ucational attainment, and age at first injection; and 4) cij and
ci are random intercepts that account for the clustering of
visits within persons and persons within neighborhoods, re-
spectively.
We accounted for measured time-varying confounding
and right censoring due to losses to follow-up by variables
in L ijk by fitting the hierarchical logistic regression model
specified above with stabilized IPWs of the form


















Cijk1 ¼ 0j Cijk2 ¼ 0; Xijk1;L ijk2
;
where the weight SWXijk accounts for measured confounding
and the weight SWCijk accounts for selection bias due to
measured determinants of loss to follow-up. The condi-
tional density function evaluated at the observed covariate
values for a given participant is represented by
f ½dj d,L ijk2 is a vector of time-varying covariates mea-
sured at visit k  2, including the baseline covariates Vij0,
and Cijk2 ¼ 0 if participant j is censored by visit k  1. For
this study, a participant was censored if he or she was lost
to follow-up but not if the outcome was present. Specifi-
cally, a visit was considered lost to follow-up if 1) there
was a greater than 2-year interval between visits or 2) the
visit was the last visit for a respondent and it occurred more
than 2 years prior to the end of follow-up in 2005. We
estimated SWXijk using pooled multinomial logistic regres-
sion. Predicted probabilities for the numerator and denom-
inator were assigned based on the category of actual
exposure to neighborhood poverty at each visit and were
then divided to obtain the stabilized IPW. SWCijk was
obtained by using pooled logistic regression, as described
elsewhere (51).
To estimate causal effects, it is important to maintain the
temporal sequence between potential confounders, expo-
sure, and outcome. As such, we lagged the exposure Xijk
by one visit and lagged time-varying covariates L ijk by 2
visits. We decided not to include covariates in L ijk measured
at the same visit as the outcome, Xijk, in weight models that
accounted for time-varying confounding. Although doing so
may have introduced residual confounding, the addition of
nonconfounding variables, including mediators, in weight
models may induce selection bias due to collider stratifica-
tion (23, 52), induce finite sampling bias (38), and decrease
the statistical efficiency of the effect estimate (53).
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